In fact, the overall CPHI Pharma Index – a collateralised metric of all major ranking categories – has risen by more than 8%, the largest year-on-year gain in the survey’s six year history
Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe
Ryzneuta is a novel dimeric G- CSF long-acting fusion protein without pegylation. The Biologics License Application (BLA) of Ryzneuta is currently under late-stage review by the US FDA for Chemotherapy-Induced Neutropenia (CIN)
The product is expected to be launched by Q4 FY23.
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
Ties up with Denmark’s Vestfrost Solutions, to cater to the unique needs of the Indian market
Dr. Mandaviya agreed to host the Stop TB Partnership’s 36th Board meeting on March 25-26, 2023 in Varanasi
Viehbacher brings extensive international experience in large pharmaceutical and entrepreneurial biotech companies
The company is making its entry into the Hyderabad market through its unique asset-light business model
ASG is accelerating its doctor-led mission to enhance the quality of care, deliver eye care for all, and improve quality of life across India.
Subscribe To Our Newsletter & Stay Updated
